Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
All that and not a word as an alleged shareholder about expecting the company to deal with semi convincing allegations of a corrupt trial.
Nem likely knows if he quit you'd all just sweep it under the rug.
Maybe Mercidenzel?? Eye rolls.
That's what they're counting on from retail, IMO.
>>I'm just holding and waiting, and trying to stay out of the drama.
Sorry about that Captain. So you know, I'm not against any worthy treatment just a management who'd hoodwink retail while taking the slow boat to China.
TALK TO THE HAND!!!
Not my CEO. Yes, that's why you have options to sell them to make money while having them replaced with a new lot. It's common. LP and the gang seem to collect them for control. Although the dilution has changed that somewhat. Enter the true-up. Wake up folks.
Bunch of mumbo jumbo, TMKIPK.
Your CEO CFO Chair is running her own CDMO on another continent and currently had no NWBO employee contract in place. Just an observation.
"NHS watchdog blocks breast cancer drug in England"
Almost certainly L's fate based on this Plll.
>>But Nice said the effect on patient life expectancy was not clear.
https://www.ft.com/content/5ebcea4a-4956-421d-a014-3f0b37bde5f3
In the meantime investors will focus on reality.
https://www.fiercebiotech.com/biotech/aacr-24-cancer-vaccines-get-reintroduction-technology-finally-comes-together
Trial after GBM trial, recruiting 100...200...300 patients as DCVAX struggles through just one ancient trial while failing to trial any other disease and shelving Direct. Crazy.
https://www.onclive.com/view/aguix-receives-fda-fast-track-designation-in-glioblastoma
Maybe look under "Quiet sitting area to read the ASCO Guide". I think the booth will come up.
Based on what, they've never presented a commercial plan let alone revenue projections? Then there's the CEO CFO's private CDMO sitting in the middle of things. Not even to mention they're totally broke and running out of shares. Did I mention the CEO CFO hasn't presented in five years. Also 50,000 retail who just can't wait to get out of this thing.
>>If Approved, which Imo is likely, I see a rise in PPS. Maybe a pop above a buck or two if we are lucky.
Clearly you're into rigging the system, you loser.
Odds for approval or odds for retail ever making a dime?
Seriously?...Orphan jokes. Geez. When will you teenage disciples buy yourselves a sense of humor.
Change your meds?
Hard to believe all you 24/7 pumping disciples aren't going to ASCO to meet your savior, assuming she's even there, of course.
They complain about you but ignore press like this.
https://www.intelligenceonline.com/corporate-intelligence/2023/01/18/cofer-black-former-cia-counterterrorism-center-chief-has-colourful-history-on-corporate-boards,109903391-art
Don't worry Feuerstein will take some pictures. Look for any Advent signage.
"ASCO thunder". LOL!!!
The company can't even produce a PR or highlight video. Year after year just hearsay.
My guess is the date was chosen when it was realized the court wasn't going to back off its True-up decision and the plaintiff wouldn't settle. Meanwhile the plaintiff is in discovery mode even as LP takes another whack at the same options package (which I alone here seem to find very odd). "Management" really needs to provide more information to shareholders on potential outcomes, IMO.
Looks like it's a shell now. Big Al's specialty.
>>The reporting requirements are detailed in the Securities Exchange Act of 1934. They are extensive and can be burdensome for small publicly-listed firms. Some of these experience very little trading of their stock on the public exchange. Ownership may be dominated by a single family or by a small group of investors. For such circumstances, the benefits of being a public company may simply not be worth the time, money, and effort of preparing and filing periodic reports to the SEC.
>>As soon as the voluntary Form 15 is filed, the company is no longer required to make the principal filings required by the SEC. These include the annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K.
Thanks, Ex.
You'll also notice the disciples here have no sense of humor whatsoever almost like they're one and the same or all just following a daily script.
NOT IN A MILLION YEARS! LOL
Thanks but that's a little too much information. LOL.
For anyone doubting Nemesis is British here's indisputable proof. Lol.
"Suffers from diseased tooth which look inflammed with open cavities"
Is Les a member of SAG?
>>They pay Less $750K to go on big booze show to let everyone know if ANYTHING is happening in the near future, it's not until fall.
It's as if NWBO and DCVAX don't even exist in the eyes of healthcare experts and Wall St. It spells "Research for researches sake" along with great salaries, perks and private business endeavors.
>>The chief executive remains confident in the oncology side of CB-010's development program as well, with the company poised to unveil data at the upcoming American Society of Clinical Oncology meeting this week.
When Nemesis first appeared with his story I told you people to report him to the company right away to see how they'd respond to a potentially share price deflating scheme. As predicted we heard nothing from them but instead, you all took it upon yourselves to convince others Nemesis wasn't the real deal. Typical.
Just keep it simple. Whatever might've happened with the alleged spoofing the share price would still be in the dumps today given the lack of communication.
>>It is because of them
Powerful! I'm surprised they didn't try to bump you off. LOL
"Ironically, my general health and wellbeing improves the less I see
ofOncological Specialists for they exist in a World of Presumption vs Facts."
They will reverse split your shares but never true them up.
Because that particular lawyer chases excessive options packages hoping for a settlement of some sort. Just going for the low hanging fruit. She might not even know NWBO is a biotech. Lol. That's my take but someone may know different. Looks like a couple of shareholders joined in but we haven't heard from anyone.
The real question is who gets to keep shareholders money?
You have a lot of catching up to do.
That's why LP set it up for only retail. Because they're unorganized, broke, and uneducated in these governance matters. The True-up case was brought by a lawyer initially, btw.
Oh god, yet another narrative is hatched. This should last a week or so. LOL
Also, Alfred, SirVaxM was born in a lab just 10 years ago while DCVAX is going on 30.
Hey Ex, did we ever see a Confidential Treatment filing for Advent like LP did with Cognate?